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Abstract
Background: Staphylococcus aureus is among the most common pathogens isolated from blood cultures in
Ghana; yet the epidemiology of blood infections in rural settings is poorly described. This study aims to
investigate antimicrobial susceptibility and clonal diversity of S. aureus causing bloodstream infections in two
hospitals in the Ashanti Region, Ghana.
Methods: Blood cultures were performed for all febrile patients (≥37.5 °C) on hospital admission. Antibiotic
susceptibility testing for S. aureus isolates was carried out by the VITEK 2 system. Multiplex polymerase chain reaction
(PCR) was used to detect S. aureus-specific nuc gene, Panton-Valentine leukocidin (PVL), and methicillin-resistant
S. aureus (MRSA)-specific mecA and mecC genes. The population structure of S. aureus was assessed by spa typing.
Results: In total, 9,834 blood samples were cultured, out of which 0.6% (n = 56) were positive for S. aureus.
Multidrug resistance (MDR) was detected in 35.7% (n = 20) of the S. aureus strains, of which one was a MRSA.
The highest rate of antibiotic resistance was seen for commonly available antibiotics, including penicillin (n = 55;
98.2%), tetracycline (n = 32; 57.1%) and trimethoprim/sulfamethoxazole (n = 26; 46.4%). Of all S. aureus strains, 75.
0% (n = 42) carried the PVL-encoding genes. We found 25 different spa types with t355 (n = 11; 19.6%), t314 (n = 8; 14.
3%), t084 (n = 8; 14.3%) and t311 (n = 5; 8.9%) being predominant.
Conclusion: The study exhibited an alarmingly large level of antibiotic resistance to locally available antibiotics. The
frequency of genetically diverse and PVL-positive methicillin-sensitive S. aureus (MSSA) was high and could represent a
reservoir for the emergence of virulent PVL-positive MRSA clones.
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Background
Globally, Staphylococcus aureus is responsible for a var-
iety of human infections including skin diseases, but also
causing bacteraemia and sepsis [1]. In Ghana, S. aureus
is the most frequently isolated pathogen from clinical
specimens from hospitalized patients and ranks second
among clinical isolates from outpatients [2]. Data from
Ghanaian urban tertiary care hospitals have shown low
antibiotic resistance and low rates of methicillin-
resistant S. aureus (MRSA) [3]. In fact, low prevalence of
invasive MRSA has been reported from several major
towns in different African countries [4]. In contrast, a
common attribute of S. aureus strains found in African
communities appears to be the carriage of Panton-Val-
entine leukocidin (PVL), which is found at much
higher rates than elsewhere [3, 5, 6]. There is evidence
that PVL-positive isolates are more frequently de-
tected in clinical isolates compared to asymptomatic
colonization [7]. PVL is a cytotoxin encoded by the
two genes lukS-PV and lukF-PV and thought to be
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associated with increased disease severity [8, 9], al-
though its role in disease pathogenesis remains contro-
versial [10, 11]. Studies have shown that some virulence
factors such as PVL are frequently associated with cer-
tain genotypes [12]. In several studies S. aureus isolates
from Ghana from different clinical samples and from
nasal carriage have been characterized. In particular for
rural settings, only few studies have investigated the
clonal structure of isolated strains from blood cultures
of febrile patients. However, these investigations are
essential to develop and establish infection control
strategies.
The objective of this study was to investigate antibiotic
susceptibility, clonal diversity, and the occurrence of
PVL in invasive S. aureus from blood cultures in the
rural Ashanti Region, Ghana.
Methods
Study site, study population and ethical considerations
The study was conducted at two rural hospitals in the
Ashanti Region in Ghana: the St. Michael’s Hospital
(SMH) in Pramso in the Bosomtwe district and the
Agogo Presbyterian Hospital (APH), situated in the
Asante Akim North municipality.
Patients of all age groups, admitted to the hospitals
with a tympanic temperature ≥ 37.5 °C or a history of
fever in the last 24 h as well as neonates (aged ≤ 28 days)
with suspected neonatal sepsis, were eligible for enrol-
ment in this study. Excluded were patients with surgical
or dermatological conditions. The study was conducted
between May 2007 and August 2012, with different sam-
pling periods at each hospital.
Laboratory procedures
On admission, patient’s blood was drawn for blood cul-
ture. Small volumes of blood (1–3 ml) were inoculated
into Becton Dickinson (BD) BACTEC® Peds Plus
Medium and 8–10 ml of blood were inoculated into BD
BACTEC® Plus Aerobic/F (Becton Dickinson, USA).
Cultures were processed using a BACTEC® 9050 blood
culture system (Becton Dickinson, USA) according to
manufacturer’s instructions. For positive blood cultures,
aspirated blood culture fluid was Gram stained for pre-
liminary identification and inoculated on Columbia
blood-, chocolate-, and MacConkey agar (all Oxoid,
Basingstoke, UK). The plates were incubated at 37 °C
for 18–24 h. Staphylococci isolates were presumptively
identified by catalase positivity, free coagulase produc-
tion (lyophilized rabbit plasma, bioMerieux, Marcy
l’Etoile, France), and agglutination in the Staphaurex™
Plus test (Oxoid).
All bacterial strains were sent to Germany on dry ice
for further analyses. Species identification of all
Staphylococcus isolates was confirmed by MALDI-TOF
MS (Bruker UK Limited, England) and by PCR detection
of the S. aureus-specific nuc gene [13]. Antibiotic suscepti-
bility testing was performed using the VITEK 2 system
(AST 603 cards, bioMerieux, France) for penicillin, oxacil-
lin, gentamicin, ciprofloxacin, moxifloxacin, erythromycin,
clindamycin, linezolid, teicoplanin, vancomycin, tetracyc-
line, tigecycline, fosfomycin, fusidic acid, rifampicin and
trimethoprim/sulfamethoxazole. Breakpoints were applied
according to the 2015 European Committee on Anti-
microbial Susceptibility Testing (EUCAST) guidelines
(http://www.eucast.org). Multidrug resistance (MDR) was
defined as resistance to at least three groups of antibiotics
or being an MRSA [14].
DNA extraction and molecular typing
DNA was extracted using the automated QIAsymphony
SP/AS instruments (QIAGEN, Germany). A multiplex
PCR was used targeting the genes encoding PVL (lukS-PV
and lukF-PV) and mecA and mecC, as described previ-
ously [13].
Sequence-based typing of the hypervariable region of S.
aureus protein A (spa-typing) was performed as described
by Harmsen and colleagues [15]. Spa types were assigned
using the Ridom StaphType software version 2.2.1 (Ridom
GmbH, Würzburg, Germany). Cluster analysis of spa typ-
ing data was performed by application of the integrated
Based Upon Repeat Patterns (BURP) algorithm as de-
scribed elsewhere [16]. The associated MLST-based se-
quence types or MLST-CCs were allocated by the Ridom
SpaServer (http://spaserver.ridom.de), retrieved from the
literature [1, 3, 12, 17, 18], or derived from closely related
spa-types.
Statistical analysis
Descriptive statistics were performed. Dichotomous vari-
ables were described using frequencies and their propor-
tion. Continuous variables were described using the
median along with the interquartile range (IQR). All
analyses were conducted using Stata Statistical Software
14 (College Station, TX: StataCorp LP).
Results
Bacterial bloodstream infections
In this study, a total of 9,834 blood samples were proc-
essed. Study participants were 1 day to 80 years old.
Median age of the study participants was 3 years (IQR:
1–10). 50.7% (n = 4,973) of the study participants were
male. Of all blood culture samples, 14.3% (n = 1,410)
showed bacterial growth including pathogens and con-
taminants such as skin flora and soil bacteria. From all
blood cultures, 56 (0.6%) S. aureus were isolated.
Study participants with S. aureus-positive blood cul-
tures had a median age of 3 years (IQR 0–13 years)
and 66.1% (n = 37) were male.
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Antimicrobial susceptibility
All S. aureus were sensitive to gentamicin, ciprofloxacin,
linezolid, teicoplanin, vancomycin, tigecycline, fosfomy-
cin, fusidic acid, rifampicin and moxifloxacin (Table 1).
Inducible clindamycin resistance was not detected in
any of the isolates.
The highest rate of resistance was for penicillin (n = 55;
98.2%) followed by tetracycline (n = 32; 57.1%) and tri-
methoprim/sulfamethoxazole (n = 26; 46.4%). In total,
35.7% (n = 20) of S. aureus were MDR, of which one was
confirmed mecA-positive MRSA. MDR strains were most
commonly resistant to the antibiotics penicillin, tetracyc-
line and trimethoprim/sulfamethoxazole (n = 18; 90%).
S. aureus spa types and detection of PVL
Twenty-five different spa types were identified in the
isolates (Table 2). The most prevalent were t355 (n = 11;
19.6%) followed by t314 (n = 8; 14.3%), t084 (n = 8;
14.3%) and t311 (n = 5; 8.9%). The most frequent se-
quence types (ST) were ST152 (n = 17; 32.1%), followed
by ST121 (n = 14; 26.4%) and ST15 (n = 9; 17.0%). The
prevalence of PVL-positive isolates among all S. aureus
was 75% (n = 42). Notable is that all isolates belonging to
ST121 (n = 14; 100%) and ST152 (n = 17; 100%) and
55.6% (n = 9) of ST15 were PVL-positive. The MRSA
isolate was PVL-negative spa type t786.
Discussion
We found very high rates of resistance in particular to
penicillin but also to tetracycline and trimethoprim/
sulfamethoxazole. African S. aureus strains from clinical
infections are known to display high rates of resistance
to the above-mentioned antibiotics but are also charac-
terised by low resistance to other antibiotics indicated to
treat infections with gram-positive bacteria [19–21]. This
might reflect the frequent and repeated administration
of locally available antibiotics, thus selecting for resist-
ance and resulting in high frequencies of MDR. Our
findings were in line with another study conducted in
Ghana, where 32.1% of S. aureus isolated among differ-
ent clinical specimens, including blood cultures, from
urban and semi-urban hospitals, were reported being
MDR [3]. In another Ghanaian study by Egyir et al., high
proportions of S. aureus resistant to penicillin and tetra-
cycline (97% and 42%, respectively) were seen in a col-
lection of clinical samples, similar to what we observed
in our study [3]. In contrast, the level of resistance for
trimethoprim/sulfamethoxazole in our study was much
higher (46%) as described in 2012 by Egyir et al. for
urban and semi-urban Ghana (4%) [3] and more than
twice as high as was described by Breurec et al. for Afri-
can urban areas in Morocco, Cameroon, Madagascar,
Niger and Senegal [4]. This might be due to overuse of
this antibiotic in the past years in this particular rural re-
gion of Ghana, where the choice of drugs is limited.
We found only one MRSA among the S. aureus iso-
lates (2%), which was similarly low to what was de-
scribed by Egyir et al. (3%), and much lower than what
was reported across the African continent [17, 22]. A
study involving five major African towns reports an
overall MRSA prevalence of 15% in clinical samples [4],
and an even higher prevalence has been described in a
Nigerian study (20%) [22]. The low frequency of MRSA
observed in our study may be due to reduced drug pres-
sure in the rural area under observation that may result
from low prescription of third generation cephalosporins
as these drugs tend to be more expensive [23].
In general, spa typing showed high genetic diversity as
shown by the recovery of 25 different spa types from the
isolates tested. The single detected MRSA isolate be-
longs to the typical MRSA clone of sequence type ST88
(t786) predominantly found in East, Central and West
Africa [21]. Spa types t355, t084, and t314 were among
the four most common spa types identified and are
known to circulate in Ghana [3, 24]. These spa types
have also been described as typical African clones in
other studies [17, 25, 26]. Indeed, the results confirm
stable populations of clinical S. aureus isolates in sub-
Saharan Africa.
With regard to PVL, Africa has been considered a
PVL-endemic region with very high rates of PVL-
Table 1 Percentage antibiotic resistance in Staphylococcus
aureus isolates
Drug Number of resistant isolates (%)
N = 56
Oxacillina 1 (1.8)
Penicillina 55 (98.2)
Ciprofloxacinb 0 (0)
Moxifloxacinb 0 (0)
Teicoplaninc 0 (0)
Vancomycinc 0 (0)
Clindamycind 1 (1.8)
Erythromycind 2 (3.6)
Fosfomycind 0 (0)
Fusidic acidd 0 (0)
Gentamicind 0 (0)
Linezolidd 0 (0)
Rifampicind 0 (0)
Tetracyclined 32 (57.1)
Tigecyclined 0 (0)
Trimethoprim/Sulfamethoxazoled 26 (46.4)
aB-lactams
bquinolone/fluorquinolones
cglycopeptides
dindividual other group
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producing S. aureus strains (17%–74%), in particular
MSSA [12, 17]. This was also emphasized in our study
with PVL at 75%, which is among the highest prevalence
described so far. Studies highlight the association of cer-
tain sequence types with the production of PVL mainly
involving ST15, ST121 and ST151 [12]. Even though no
statistical analyses were carried out due to low numbers,
we observed a trend confirming this association in our
bacterial isolates.
Conclusion
The study demonstrated a high frequency of PVL-
positive and genetically diverse MSSA lineages isolated
from blood cultures in rural Ghana. The strains were
characterised by high antibiotic resistance to commonly
available antibiotics and low rates of MRSA and anti-
biotic resistance to other drugs specifically indicated for
S. aureus infections.
The acquisition of the mecA and mecC genes by PVL-
positive MSSA and hence the spread of PVL-positive
MRSA could present a considerable challenge in disease
management and infection control in the near future.
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Table 2 Bacterial population structure of invasive Staphylococcus aureus isolates
CC (n) ST (n) spa type (n) Repeat pattern (aligned) lukS-PV/lukF-PV [Frequency (%)]
CC152 (17) ST152 (17) t355 (11) 07-56-12-17-16 -16-33-31-57-12 17 (100.0)
t15285 (2) 07-56-12-17-342-16-33-31-57-12
t1123 (1) 07-56-12-17-16 -16- -31-57-12
t1299 (1) 07-56-12-17-16 - -33-31-57-12
t15281 (1) 07-56-12-17-16 -16-33-31-21-12
t15283 (1) 07-56-12-17-16 -16-33-31-57-12-12-12
CC121 (14) ST121 (14) t314 (8) 08- -17-23-18-17 14 (100.0)
t2304 (3) 08- -17-23-24
t645 (1) 14-44-13-12-17-23-18-17
t1077 (1) 14-44- -12-17-23-18-17
t1114 (1) 14-44-13-17-23-1-17
CC15 (9) ST15 (9) t084 (8) 07-23-12-34-34-12-12- -23-02-12-23 5 (55.6)
t2339 (1) 26-23-12-34-34-12-12-12-23-02-12-23
CC5 (6) ST5 (5) t311 (5) 26-23-17-34-20-17-12-17-16 1 (20.0)
ST6 (1) t701 (1) 11-10-21-17-34-24-34-22-25-25 0 (0.0)
CC1 (2) ST1 (2) t127 (1)
t591 (1)
07-23- -21-16-34-33-13 1 (50.0)
07-23-21-21-16-34-33-13
CC30 (2) ST30 (2) t363 (1) 15-16-02-25-17-24 2 (100.0)
t8072 (1) 15-16-02-25- -24
CC88 (2) ST88 (2) t448 (1) 07-12-21-17-13-13-34- -33-34 1 (50.0)
t786 (1) 07-12-21-17-13- -34-34-33-34
CC8 (2) ST8 (1) t008 (1) 11-19-12-21-17-34-24-34-22-25 0 (0.0)
unknown (1) t15282 (1) 11-10- -21-10-34-24-34-22-25-25
CC45 (1) ST508 (1) t861 (1) 08-16-02-16-34-34-13-17-34-16-13 0 (0.0)
CC80 (1) ST80 (1) t376 (1) 07-23-12-34-34-34-33-34 1 (100.0)
Abbreviation: CC: clonal complex, ST: sequence type
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